https://www.selleckchem.com/pr....oducts/hmpl-504-azd6
Ipsilateral nonstenotic carotid disease is increasingly recognized as an etiology of ischemic stroke, however tailored treatment strategies are lacking. We aimed to examine clinical characteristics and treatment effects in patients with minor ischemic stroke associated with ipsilateral nonstenotic carotid disease in the Platelet Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trial. We performed an exploratory analysis of the interaction of the treatment effects of aspirin plus clopidogrel versus aspi
Like
Comment
Share
